A detailed history of Miracle Mile Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Miracle Mile Advisors, LLC holds 31,917 shares of ABBV stock, worth $5.84 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
31,917
Previous 29,673 7.56%
Holding current value
$5.84 Million
Previous $5.09 Million 23.84%
% of portfolio
0.15%
Previous 0.13%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$163.84 - $199.33 $367,656 - $447,296
2,244 Added 7.56%
31,917 $6.3 Million
Q2 2024

Jul 18, 2024

BUY
$154.79 - $180.76 $66,559 - $77,726
430 Added 1.47%
29,673 $5.09 Million
Q1 2024

Apr 18, 2024

BUY
$159.82 - $182.1 $287,835 - $327,962
1,801 Added 6.56%
29,243 $5.33 Million
Q4 2023

Jan 22, 2024

BUY
$137.6 - $154.97 $63,296 - $71,286
460 Added 1.7%
27,442 $4.25 Million
Q3 2023

Oct 25, 2023

SELL
$133.59 - $154.65 $447,927 - $518,541
-3,353 Reduced 11.05%
26,982 $4.02 Million
Q2 2023

Jul 13, 2023

SELL
$132.51 - $164.9 $226,592 - $281,979
-1,710 Reduced 5.34%
30,335 $4.09 Million
Q1 2023

Apr 20, 2023

BUY
$144.61 - $166.54 $117,423 - $135,230
812 Added 2.6%
32,045 $5.11 Million
Q4 2022

Jan 20, 2023

BUY
$138.31 - $165.87 $105,668 - $126,724
764 Added 2.51%
31,233 $0
Q3 2022

Oct 24, 2022

SELL
$134.21 - $153.93 $590,792 - $677,599
-4,402 Reduced 12.62%
30,469 $4.09 Million
Q2 2022

Jul 15, 2022

SELL
$137.62 - $174.96 $46,377 - $58,961
-337 Reduced 0.96%
34,871 $5.34 Million
Q1 2022

Apr 25, 2022

BUY
$131.98 - $163.75 $330,873 - $410,521
2,507 Added 7.67%
35,208 $5.71 Million
Q4 2021

Jan 18, 2022

BUY
$107.43 - $135.93 $2.14 Million - $2.71 Million
19,900 Added 155.46%
32,701 $4.43 Million
Q3 2021

Nov 01, 2021

BUY
$106.4 - $120.78 $650,529 - $738,448
6,114 Added 91.43%
12,801 $1.38 Million
Q2 2021

Jul 28, 2021

SELL
$105.21 - $117.21 $223,886 - $249,422
-2,128 Reduced 24.14%
6,687 $753,000
Q1 2021

Apr 29, 2021

BUY
$102.3 - $112.62 $12,992 - $14,302
127 Added 1.46%
8,815 $954,000
Q4 2020

Jan 19, 2021

BUY
$80.49 - $108.67 $302,561 - $408,490
3,759 Added 76.26%
8,688 $934,000
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $184,620 - $216,683
2,149 Added 77.3%
4,929 $432,000
Q2 2020

Aug 06, 2020

SELL
$73.37 - $98.18 $22,084 - $29,552
-301 Reduced 9.77%
2,780 $273,000
Q1 2020

May 11, 2020

SELL
$64.5 - $97.79 $226,846 - $343,927
-3,517 Reduced 53.3%
3,081 $235,000
Q4 2019

Feb 10, 2020

BUY
$72.13 - $90.25 $2,813 - $3,519
39 Added 0.59%
6,598 $584,000
Q3 2019

Nov 06, 2019

SELL
$62.98 - $75.72 $78,599 - $94,498
-1,248 Reduced 15.99%
6,559 $497,000
Q2 2019

Aug 07, 2019

BUY
$65.7 - $83.98 $164,250 - $209,950
2,500 Added 47.11%
7,807 $568,000
Q1 2019

May 07, 2019

BUY
$77.14 - $90.79 $7,714 - $9,079
100 Added 1.92%
5,307 $428,000
Q4 2018

Jan 22, 2019

SELL
$77.85 - $96.01 $5,293 - $6,528
-68 Reduced 1.29%
5,207 $480,000
Q2 2018

Aug 08, 2018

BUY
$89.78 - $106.23 $26,934 - $31,869
300 Added 6.03%
5,275 $489,000
Q1 2018

May 02, 2018

BUY
$92.01 - $123.21 $18,402 - $24,642
200 Added 4.19%
4,975 $471,000
Q4 2017

Feb 07, 2018

BUY
$89.56 - $98.21 $427,649 - $468,952
4,775
4,775 $462,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $324B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Miracle Mile Advisors, LLC Portfolio

Follow Miracle Mile Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Miracle Mile Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Miracle Mile Advisors, LLC with notifications on news.